Sugi Predict
/ Targets
/ ITPA
Top predicted compounds (top 20 by supporting neighbours, then confidence)
| Compound | Confidence | Supporting neighbours |
Clinical trials — most relevant to ITPA by text similarity (a relevance ranking, not an exhaustive list)
| Trial | Phase | Status |
| Alendronate Versus Denosumab in Kidney Transplant Patients |
PHASE2/PHASE3 | COMPLETED |
| Acelarin First Line Randomised Pancreatic Study |
PHASE2/PHASE3 | SUSPENDED |
| Preventing Acute Kidney Injury (AKI) in Pediatric Patients |
PHASE3 | UNKNOWN |
| Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients |
PHASE2 | COMPLETED |
| Pentoxifylline as an Adjunctive in Treatment of Negative Symptoms in Chronic Schizophrenia |
PHASE1/PHASE2 | COMPLETED |
| NEO100 and High-Grade Meningioma |
PHASE2 | RECRUITING |
| A Clinical Study of NAD in the Treatment of Immune Thrombocytopenia |
PHASE1/PHASE2 | RECRUITING |
| ASPirin in Immune thRombocytopenia Patients With Cardiovascular disEase |
PHASE2 | COMPLETED |
| University of California, San Diego (UCSD) Suramin Autism Treatment-1 (SAT1) Trial |
PHASE1/PHASE2 | COMPLETED |
| Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma |
PHASE1/PHASE2 | COMPLETED |
| A Study of ES002023 (Anti-CD39 Antibody) in Patients With Locally Advanced or Metastatic Solid Tumors |
PHASE1 | COMPLETED |
| Safety, Tolerability and Pharmacokinetics of Benfo-Oxythiamine (B-OT) in Healthy Volunteers |
PHASE1 | COMPLETED |
| A Phase I Trial of AVN944, an IMPDH Inhibitor, in Adults With Advanced Stage Solid Tumors |
nan | WITHDRAWN |
| An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers |
nan | COMPLETED |
| Study of the Pathophysiological Mechanisms Involved in Bleeding Events |
nan | COMPLETED |
| Role and Interactions of Adenosine, Receptors, Methionine Cycle Nutritional, Metabolic and Genetic Determinants in the Onset of Atrial Fibrillation in Normal Heart |
nan | UNKNOWN |
| Diadenosine Polyphosphates and Mucin Associated With Ocular Surface Disorders |
nan | UNKNOWN |
| Catheter Placement for Hepatic Hydrothorax |
nan | COMPLETED |
| Unraveling Genetics of HypoPhosPhatasia (HPP Genetics) |
nan | COMPLETED |
| Glycine and Magnesium+Thiamine for the Treatment of Primary Ciliary Dyskinesia |
nan | RECRUITING |
| The Effect and Frequency of Helicobacter Pylori Infection in Primary Immune Thrombocytopenic Patients |
nan | UNKNOWN |
| Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene Mutations in Acromegaly |
nan | UNKNOWN |
| 99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis |
nan | COMPLETED |
| Effect of Single-nucleotide Polymorphism of CD40 Gene rs1883832 C/T on the Risk of Immune Thrombocytopenic Purpura |
nan | UNKNOWN |
| Cognitive Status, Fatigue and Inflammation in Patients With Immune Thrombocytopenia (ITP) |
nan | COMPLETED |
| Exome Sequencing for Atypical Femoral Fractures |
nan | COMPLETED |
| Longitudinal Assessment of Atypical Tripeptidyl Peptidase 1 Enzyme Deficiency Patients |
nan | ACTIVE_NOT_RECRUITING |
| Studying Phosphorus Metabolism |
nan | COMPLETED |
| Effect of Polymorphisms in the Adenosine a2a Receptor Gene and AMPD2 Gene on Adenosine-Induced Vasodilation and Reactive Hyperemia |
nan | COMPLETED |
| Immune Signature of Palmoplantar Pustulosis |
nan | COMPLETED |
Related proteins — ESM-2 sequence neighbours (a ITPA binder may also engage these)